metyrapone has been researched along with Benign Hypothalamic Neoplasms in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Streeten, DH | 1 |
| Anderson, GH | 1 |
| Dalakos, TG | 1 |
| Seeley, D | 1 |
| Mallov, JS | 1 |
| Eusebio, R | 1 |
| Sunderlin, FS | 1 |
| Badawy, SZ | 1 |
| King, RB | 1 |
1 review available for metyrapone and Benign Hypothalamic Neoplasms
| Article | Year |
|---|---|
Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.
Topics: 17-Hydroxycorticosteroids; Acromegaly; Adenoma, Chromophobe; Adolescent; Adrenocorticotropic Hormone | 1984 |